Additional resources for the MRCT Center sponsors in our Covid-19 Guidance Repository.
- COVID-19 “Should I Join” Research flyers: Helpful resource to prepare potential clinical trial participants (patients, friends/family members, parents/guardians, and children for recruitment and consent.
- COVID-19 Health Literacy project: The COVID19 Health Literacy Project is useful for general information on COVID-19 in 30 languages.
- CDC Coronavirus 2019 microsite: Find up to date information and resources on the Coronavirus Disease 2019 pandemic provided by the Centers for Disease Control and Prevention:
- WHO Coronavirus Resources: Find up to date information and resources on the Coronavirus Disease 2019 pandemic provided by the World Health Organization.
- Caring for Your Mental Health Despite the Coronavirus: Mclean Hospital offers helpful tips in managing your mental health needs during this pandemic.
- Harvard Medical School Coronavirus Resource Center
- “Diagnostic Testing for COVID-19: Considering False Positive and False Negative Results” by MRCT Center Program Director, Deborah A. Zarin, MD and Joseph Lau, MD, Professor Emeritus of Health Services, Policy and Practice, Center for Evidence Synthesis in Health, Brown University School of Public Health
PEDIATRICS
- 7 Ways to Support Kids and Teens Through the Coronavirus Pandemic: The Clay Center for Young Healthy Minds at Massachusetts General Hospital provides helpful ways to help support kids and teens through this stressful time.
- Children’s story book released to help children and young people cope with COVID-19
- Activities & Resources for While You’re Home with Kids with Special Needs
- Suggested COVID-19-Related Resources for the Autism Community
- iCAN: Kids and COVID-19
- Ropes & Gray’s summary of COVID-19 disruptions of international clinical trials: Comparison of guidance documents issued by FDA, EMA, MHRA, and PMDA
- COVID-19 Disruptions of International Clinical Trials: From Ropes & Gray, comparing Guidances Issued by Key European National Regulatory Authorities, the Australian Department of Health, Brazil’s ANVISA, Health Canada and Singapore’s HSA
- U.S. Food and Drug Administration (FDA): FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic (April 16, 2020)
- European Medicines Agency (EMA): Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic (March 27, 2020)
- United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA): Managing clinical trials during Coronavirus (COVID-19) (March 24, 2020)
- Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)
- OHRP Guidance on COVID-19
- HHS Novel Coronavirus Resources
- Guidance for HMS Community around Coronavirus (COVID-19)
- The European Medicines Agency (EMA) Coronavirus disease (COVID-19) Resources
- PCORI COVID-19 Updates
- COVID-19 “Should I Join” Research flyers: Helpful resource to prepare potential clinical trial participants (patients, friends/family members, parents/guardians, and children for recruitment and consent.
- COVID-19 Collaboration Platform: a home for clinical trial protocols that are available for collaboration. Effective treatments for COVID-19 can be found much faster by sharing protocols for and data from clinical trials.
- COVID Case Report Forms and Phenotyping Standards
- COVID-19 Research Resources Hub
- COVID-19 Research Database
- CDISC Interim User Guide
- Responses to Top Questions from Responsible Parties Related to Coronavirus (COVID-19)
PEDIATRICS
- Guidelines on the Management of Paediatric Patients during COVID-19 Pandemic
- The European Association for Children in Hospital (Each) Charter
- Products and extemporaneous preparation of paediatric formulations that may be useful in the treatment of COVID-19
- A Message from AAP President Sally Goza, MD, FAAP: AAP advocacy for financial relief for pediatricians